Clincosm LogoSign in Get a demo

relapsed small cell lung cancer

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)

Recruiting
  • Relapsed Small Cell Lung Cancer
  • Joliet, Illinois
  • +94 more
Aug 12, 2022

Relapsed Small Cell Lung Cancer, Refractory Small Cell Lung Carcinoma Trial (Venetoclax 50 MG, Venetoclax 100 MG, Venetoclax 200

Withdrawn
  • Relapsed Small Cell Lung Cancer
  • Refractory Small Cell Lung Carcinoma
  • Venetoclax 50 MG
  • +6 more
  • (no location specified)
Mar 1, 2021

Relapsed Small Cell Lung Cancer, Anlotinib Trial in Hangzhou (anlotinib HCl combined with irinotecan or docetaxel)

Recruiting
  • Relapsed Small Cell Lung Cancer
  • Anlotinib
  • anlotinib hydrochloride combined with irinotecan or docetaxel
  • Hangzhou, Zhejiang, China
    Affiliated Hangzhou Cancer Hospital, Zhejiang University School
Feb 14, 2021